Meet Dr. Alexandra Sowa, MD
DUAL BOARD CERTIFIED PHYSICIAN, AUTHOR, FOUNDER
Leading the Conversation on Obesity Medicine and GLP-1 Agonist Medications
Through 10+ years of practice and as a clinical instructor at NYU School of Medicine, Dr. Sowa has developed a profound understanding of the biology of obesity and how to treat it with tools like GLP-1 agonist medications. Her extensive experience and continual research in the field have made her an expert regularly sought by major media outlets, including CNN, CBS News, and The New York Times.
Her forthcoming book, The Ozempic Revolution, hits shelves globally January 7, 2025 and is available for pre-order now!
Practicing Physician
"Most people have lost weight at one point, but it's very hard to maintain, and that's really what we're trying to set the longterm foundational change for. My goal for our community is not just weight loss, it's sustainable, long term, metabolic health.”
– Dr. Alexandra Sowa, MD
In her 10+ years of experience practicing as a dual-board certified Obesity and Internal Medicine physician, Dr. Sowa created the SoWell Method: a 360-degree treatment plan for obesity that includes the use of GLP-1 agonist medications. Her method is significantly more effective than GLP-1 medications alone.
Author
"This isn't about quick fixes or miracle cures. This is about science finally catching up to what we've long understood: obesity is a disease that requires medical intervention."
– Dr. Alexandra Sowa, MD
In her first book, The Ozempic Revolution, Dr. Sowa shares the ins-and-outs of GLP-1 medications. In it, she separates the truth from hype and empowers readers to change their lives with the help of GLP-1s alongside The SoWell Method.
Founder
“I created SoWell because, in the traditional medical environment, you get a prescription, your doctor says, ‘See you in 3 months’, and there's very little in-between. There's no nutritional support, no behavioral guidance, no education on how the brain work and all the other things that I know are necessary for success on GLP-1s. These drugs are not just magic. This process has a structure and rhyme and reason.”
– Dr. Alexandra Sowa, MD
As founder of SoWell, Dr. Sowa has created the go-to brand for GLP-1 users. With solutions for GLP-1 medication side effect management and 360-degree metabolic health support, SoWell helps fill gaps left by the traiditional medical environment.